Medpace Holdings Inc (OQ:MEDP)

Business Focus: Biotechnology & Medical Research

Jul 27, 2020 04:15 pm ET
Medpace Holdings, Inc. Reports Second Quarter 2020 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2020.
May 26, 2020 04:05 pm ET
Medpace Holdings, Inc. to Present at Two Upcoming Investor Conferences
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following two investor conferences in June:
May 18, 2020 04:05 pm ET
Medpace Holdings, Inc. to Report Second Quarter 2020 Financial Results on July 27, 2020
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2020 financial results after the market close on Monday, July 27, 2020. The Company will host a conference call the following morning, Tuesday, July 28, 2020, at 9:00 a.m. ET to discuss these results.
Apr 28, 2020 04:15 pm ET
Medpace Holdings, Inc. Reports First Quarter 2020 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2020.
Apr 03, 2020 04:05 pm ET
Medpace Holdings, Inc. to Report First Quarter 2020 Financial Results on April 28, 2020
Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced that it will report its first quarter 2020 financial results after the market close on Tuesday, April 28, 2020. The Company will host a conference call the following morning, Wednesday, April 29, 2020, at 9:00 a.m. ET to discuss these results.
Feb 24, 2020 04:15 pm ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2019.
Jan 14, 2020 04:05 pm ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2019 Financial Results on February 24, 2020
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2019 financial results after the market close on Monday, February 24, 2020. The Company will host a conference call the following morning, Tuesday, February 25, 2020, at 9:00 a.m. ET to discuss these results.
Oct 31, 2019 04:00 pm ET
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in November:
Oct 28, 2019 04:15 pm ET
Medpace Holdings, Inc. Reports Third Quarter 2019 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2019.
Sep 24, 2019 04:05 pm ET
Medpace Holdings, Inc. to Report Third Quarter 2019 Financial Results on October 28, 2019
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2019 financial results after the market close on Monday, October 28, 2019. The Company will host a conference call the following morning, Tuesday, October 29, 2019, at 9:00 a.m. ET to discuss these results.
Aug 13, 2019 04:05 pm ET
Medpace Holdings, Inc. to Present at Baird Global Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in September:
Jul 29, 2019 04:15 pm ET
Medpace Holdings, Inc. Reports Second Quarter 2019 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2019.
Jun 25, 2019 04:05 pm ET
Medpace Holdings, Inc. to Report Second Quarter 2019 Financial Results on July 29, 2019
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2019 financial results after the market close on Monday, July 29, 2019. The Company will host a conference call the following morning, Tuesday, July 30, 2019, at 9:00 a.m. ET to discuss these results.
May 21, 2019 04:05 pm ET
Medpace Holdings, Inc. to Present at Jefferies 2019 Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in June:
Apr 29, 2019 04:15 pm ET
Medpace Holdings, Inc. Reports First Quarter 2019 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2019.
Apr 08, 2019 04:05 pm ET
Medpace Holdings, Inc. to Report First Quarter 2019 Financial Results on April 29, 2019
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2019 financial results after the market close on Monday, April 29, 2019. The Company will host a conference call the following morning, Tuesday, April 30, 2019, at 8:30 a.m. ET to discuss these results.
Feb 25, 2019 04:15 pm ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2018.
Feb 07, 2019 04:05 pm ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2018 Financial Results on February 25, 2019
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2018 financial results after the market close on Monday, February 25, 2019. The Company will host a conference call the following morning, Tuesday, February 26, 2019, at 9:00 a.m. ET to discuss these results.
Feb 05, 2019 07:55 am ET
Analysis: Positioning to Benefit within Xylem, Integer, Medpace, Comstock Resources, Marriott Vacations Worldwide, and Big 5 Sporting Goods — Research Highlights Growth, Revenue, and Consolidated Resu
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Xylem Inc. (NYSE:XYL), Integer Holdings Corporation (NYSE:ITGR),...
Dec 21, 2018 05:15 pm ET
Medpace Holdings Set to Join S&P SmallCap 600
NEW YORK, Dec. 21, 2018 /PRNewswire/ -- Medpace Holdings Inc. (NASD: MEDP) will replace Green Bancorp Inc. (NASD: GNBC) in the S&P SmallCap 600 effective prior to the open of trading on Wednesday, January 2, 2019. S&P SmallCap 600 constituent Veritex Holdings Inc. (NASD: VBTX) is acquiring Green Bancorp in a deal expected to be completed soon pending final conditions....
Nov 01, 2018 04:05 pm ET
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in November:
Nov 01, 2018 08:50 am ET
Detailed Research: Economic Perspectives on Watsco, T-Mobile US, Medpace, eHealth, AllianceBernstein Holding, and Limelight Networks — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Watsco, Inc. (NYSE:WSO), T-Mobile US, Inc. (NASDAQ:TMUS), Medpace...
Oct 29, 2018 04:15 pm ET
Medpace Holdings, Inc. Reports Third Quarter 2018 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2018.
Oct 10, 2018 07:35 am ET
Report: Developing Opportunities Within Apollo Investment, Ladder Capital, Medpace, MPLX LP, Silicon Laboratories, and Protagonist Therapeutics — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Apollo Investment Corporation (NASDAQ:AINV), Ladder Capital Corp...
Oct 03, 2018 04:05 pm ET
Medpace Holdings, Inc. to Report Third Quarter 2018 Financial Results on October 29, 2018
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2018 financial results after the market close on Monday, October 29, 2018. The Company will host a conference call the following morning, Tuesday, October 30, 2018, at 9:00 a.m. ET to discuss these results.
Aug 22, 2018 08:15 pm ET
Medpace Holdings, Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced the pricing of the previously announced secondary offering of 5,224,997 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”) at a public offering price of $55.50 per share. The offering consists entirely of secondary shares of common stock to be sold by the Selling Shareholder. Medpace will not receive any proceeds from the sale of the shares of common stock by the Selling Shareholder.
Aug 22, 2018 04:44 pm ET
Medpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced a secondary offering of 5,224,997 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”). The offering consists entirely of secondary shares of common stock to be sold by the Selling Shareholder. Medpace will not receive any proceeds from the sale of the shares of common stock by the Selling Shareholder.
Aug 15, 2018 04:30 pm ET
Medpace Holdings, Inc. to Present at Baird Global Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in September:
Aug 07, 2018 08:15 pm ET
Medpace Holdings, Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced the pricing of the previously announced secondary offering of 4,500,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”) at a public offering price of $55.00 per share. In addition, the Selling Shareholder has granted the underwriter a 30-day option to purchase up to an additional 675,000 shares of common stock from the Selling Shareholder. The offering consists entirely of secon
Aug 07, 2018 04:33 pm ET
Medpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced a secondary offering of 4,500,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”). In addition, the Selling Shareholder has granted the underwriter a 30-day option to purchase up to an additional 675,000 shares of common stock from the Selling Shareholder. The offering consists entirely of secondary shares of common stock to be sold by the Selling Shareholder. Medpace will not r
Aug 01, 2018 08:15 am ET
New Research Coverage Highlights Brunswick, Liberty Global, LaSalle Hotel Properties, Denny's, Medpace, and eHealth — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Brunswick Corporation (NYSE:BC), Liberty Global PLC (NASDAQ:LBTYA),...
Jul 30, 2018 04:15 pm ET
Medpace Holdings, Inc. Reports Second Quarter 2018 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2018.
Jul 11, 2018 04:05 pm ET
Medpace Holdings, Inc. to Report Second Quarter 2018 Financial Results on July 30, 2018
To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 7865703.
Jun 12, 2018 06:30 am ET
Medpace Holdings, Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced the pricing of the previously announced secondary offering of 3,000,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”) at a public offering price of $42.25 per share. The offering consists entirely of secondary shares of common stock to be sold by the Selling Shareholder. Medpace will not receive any proceeds from the sale of the shares of common stock by the Selling Shareholder.
Jun 11, 2018 04:28 pm ET
Medpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced a secondary offering of 3,000,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”). The offering consists entirely of secondary shares of common stock to be sold by the Selling Shareholder. Medpace will not receive any proceeds from the sale of the shares of common stock by the Selling Shareholder.
May 24, 2018 04:05 pm ET
Medpace Holdings, Inc. to Present at Jefferies Global Healthcare Conference
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in June:
May 21, 2018 07:35 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within South Jersey Industries, SITO Mobile, Ormat Technologies, Redwood Trust, Medpace, and Meridian — New Research Emphasizes Economic Gr
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of South Jersey Industries, Inc. (NYSE:SJI), SITO Mobile, Ltd. (NASDAQ:SITO),...
May 02, 2018 04:30 pm ET
Medpace Holdings, Inc. Announces Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced a secondary offering of 3,000,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”). The offering consists entirely of secondary shares of common stock to be sold by the Selling Shareholder. Medpace will not receive any proceeds from the sale of the shares of common stock by the Selling Shareholder.
Apr 30, 2018 04:15 pm ET
Medpace Holdings, Inc. Reports First Quarter 2018 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2018.
Apr 27, 2018 05:25 pm ET
Medpace Holdings, Inc. to Report First Quarter 2018 Financial Results on April 30, 2018
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2018 financial results after the market close on Monday, April 30, 2018. The Company will host a conference call the following morning, Tuesday, May 1, 2018, at 9:00 a.m. ET to discuss these results.
Mar 23, 2018 07:50 am ET
Consolidated Research: 2018 Summary Expectations for InfraREIT, Tower International, Medpace, Kaman, SEACOR, and Compass Diversified — Fundamental Analysis, Key Performance Indications
NEW YORK, March 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of InfraREIT, Inc. (NYSE:HIFR), Tower International, Inc....
Feb 27, 2018 07:00 am ET
Medpace Holdings, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Medpace Holdings, Inc. (NASDAQ: MEDP) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 9:00 AM Eastern Time.
Feb 26, 2018 04:15 pm ET
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2017 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2017.
Feb 05, 2018 04:05 pm ET
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on February 26, 2018
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2017 financial results after the market close on Monday, February 26, 2018. The Company will host a conference call the following morning, Tuesday, February 27, 2018, at 9:00 a.m. ET to discuss these results.
Jan 24, 2018 08:10 am ET
Analysis: Positioning to Benefit within Oritani Financial, Bio-Rad Laboratories, Compass Diversified, Q2, Medpace, and Engility — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Jan. 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Oritani Financial Corp. (NASDAQ:ORIT), Bio-Rad Laboratories,...
Nov 30, 2017 09:20 pm ET
Medpace Holdings, Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced the pricing of the previously announced secondary offering of 4,000,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”) at a price to the public of $31.50 per share. In addition, the Selling Shareholder has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock from the Selling Shareholder. Medpace has agreed to repurchase from the
Nov 27, 2017 04:17 pm ET
Medpace Holdings, Inc. Announces Commencement of Proposed Secondary Offering of Common Stock by Selling Shareholder
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced a proposed secondary offering of 4,000,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”). In addition, the Selling Shareholder has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of common stock from the Selling Shareholder. The offering consists entirely of secondary shares of common stock to be sold by the Selling Shareholder. Medpace will no
Oct 30, 2017 04:30 pm ET
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference
Medpace Holdings, Inc. (Nasdaq:MEDP) (“Medpace”) today announced that it will present at the following investor conference in November:
Oct 30, 2017 04:15 pm ET
Medpace Holdings, Inc. Reports Third Quarter 2017 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2017.
Oct 06, 2017 05:05 pm ET
Hillman Announces Key Management Change
CINCINNATI, Oct. 6, 2017 /PRNewswire/ -- The Hillman Companies, Inc. (NYSE-AMEX: HLM.PR) and The Hillman Group, Inc. (collectively, "Hillman" or the "Company") announced today that Robert (Rocky) Kraft will join Hillman as Chief Financial Officer and Treasurer on November 1, 2017....
Oct 04, 2017 04:01 pm ET
Medpace Holdings, Inc. to Report Third Quarter 2017 Financial Results on October 30, 2017
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2017 financial results after the market close on Monday, October 30, 2017. The Company will host a conference call the following morning, Tuesday, October 31, 2017, at 9:00 a.m. ET to discuss these results.
Sep 13, 2016 08:00 am ET
Citius Initiates Mino-Lok™ Phase 3 Trial
CRANFORD, N.J., Sept. 13, 2016 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has initiated the pivotal Phase 3 clinical trial Mino-Lok™, an antibiotic lock solution used to salvage infected central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs). ...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.